Companies /Consumer Defensive

Kimberly-Clark Corp

NYSE: KMB Household & Personal Products
$109.98
▼ $0.36 (−0.33%) today
Markets closed · 10:36pm ET

Q1 2025 Earnings

Reported Apr 22, 2025, 7:04am ET · SEC source
$1.93
Beat +2.04%
EPS · est. $1.89
$4.8B
Miss −1.10%
Revenue · est. $4.9B
−9.3%
Trailing market
KMB vs S&P since report
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−3%0+3%Apr 22Apr 23report 7:04am ETearnings+3.9%−3.5%
−3%0+3%Apr 22Apr 23earnings+3.9%−3.5%
KMB −3.5%S&P 500 +3.9%
−3%0+3%+6%Apr 22Apr 23report 7:04am ETearnings+4.7%−3.5%
−3%0+3%+6%Apr 22Apr 23earnings+4.7%−3.5%
KMB −3.5%NASDAQ +4.7%
−3%0+3%+6%Apr 21Apr 29report 7:04am ETearnings+7.0%−2.6%
−3%0+3%+6%Apr 21Apr 29earnings+7.0%−2.6%
KMB −2.6%S&P 500 +7.0%
0+4%+8%Apr 21Apr 29report 7:04am ETearnings+8.9%−2.6%
0+4%+8%Apr 21Apr 29earnings+8.9%−2.6%
KMB −2.6%NASDAQ +8.9%
−1.53%
Day of report
−3.28%
Next session
−5.34%
One week
+1.33%
30 days

S&P 500 over the same 30 days: +10.59%.

Did KMB Beat Earnings? Q1 2025 Results

Kimberly-Clark delivered a mixed first quarter for 2025, beating profit expectations while grappling with revenue headwinds and a sobering outlook revision that overshadowed the bottom-line strength. Adjusted EPS of $1.93 came in 7.22% above the $1.80 consensus estimate, though it still represented a 4.0% year-over-year decline, supported in part by a lower adjusted effective tax rate following the resolution of certain tax matters. Net sales fell 6.0% to $4.84 billion, with roughly half that decline attributable to currency translation drag and the impact of portfolio exits including the PPE divestiture. The more consequential story, however, was management's disclosure that tariff-related supply chain costs are expected to reach $300 million, prompting a sharp downgrade to full-year guidance — adjusted operating profit and EPS are now expected to be merely flat to positive on a constant-currency basis, a steep step down from the prior expectation of high single-digit growth. For investors who prize Kimberly-Clark as one of the <a href="https://247wallst.com/investing/2025/12/09/the-5-best-sp-500-dividend-aristocrat-stocks-to-buy-before-2026/">most resilient dividend growers</a> in the market, the company's 53rd consecutive year of dividend increases offered a measure of reassurance amid the uncertainty.

Key Takeaways
  • Strong in-market execution and effective cost management
  • Sustained productivity momentum fueling investments and profitability
  • Resilient consumer demand
  • Lower adjusted effective tax rate of 21.4% benefiting from resolution of certain tax matters
  • Price investments across all segments to enhance value propositions

“Building on the strong foundation we established in 2024, we made further progress across the three pillars of our Powering Care strategy in the first quarter of 2025. Despite the evolving external landscape, our first quarter was consistent with our full-year plan.”

Kimberly-Clark CEO, on the earnings call

Forward Guidance & Outlook

Kimberly-Clark significantly revised its 2025 outlook to reflect a reassessment of its cost base including potential impacts from changes in the global geopolitical landscape. Organic sales growth is expected to outpace weighted average category growth, which is currently estimated at 1.5-2.0% (down from approximately 2% at the start of the year). Reported net sales will reflect approximately 200 basis points of negative currency translation (improved from approximately 300 bps previously) and approximately 240 bps negative impact from PPE divestiture and private-label diaper exit. Adjusted operating profit is now expected to be flat to positive on a constant-currency basis, a meaningful downgrade from the prior expectation of high single-digit constant-currency growth. Adjusted EPS is now expected to be flat to positive on a constant-currency basis. Adjusted free cash flow is now expected to be approximately $2 billion, reduced from the prior expectation of more than $2 billion. The outlook reflects uncertainty around tariffs, geopolitical developments, and their impact on the global supply chain.

KMB YoY Financials

Q1 2025 vs Q1 2024 · SEC filings Q1 2024 Q1 2025
$0$2.0B$4.0B$5.1B$4.8BRevenue$1.9B$1.7BGross Profit$853.0M$769.0MOperating Income$647.0M$567.0MNet Income
$0$2.0B$4.0BRevenueGross ProfitOperating IncomeNet Income

KMB Revenue by Segment

North America$2.7B−3.9%
International Personal Care$1.4B−8.9%

Figures from SEC filings and company reports. Not investment advice.